ES2118090T3 - Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene. - Google Patents
Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene.Info
- Publication number
- ES2118090T3 ES2118090T3 ES91917473T ES91917473T ES2118090T3 ES 2118090 T3 ES2118090 T3 ES 2118090T3 ES 91917473 T ES91917473 T ES 91917473T ES 91917473 T ES91917473 T ES 91917473T ES 2118090 T3 ES2118090 T3 ES 2118090T3
- Authority
- ES
- Spain
- Prior art keywords
- medical use
- pct
- new medical
- indol
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000008548 Tension-Type Headache Diseases 0.000 abstract 2
- 206010043269 Tension headache Diseases 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909022250A GB9022250D0 (en) | 1990-10-12 | 1990-10-12 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2118090T3 true ES2118090T3 (es) | 1998-09-16 |
Family
ID=10683660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91917473T Expired - Lifetime ES2118090T3 (es) | 1990-10-12 | 1991-10-11 | Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5376672A (enExample) |
| EP (1) | EP0552205B1 (enExample) |
| JP (1) | JP3159263B2 (enExample) |
| KR (1) | KR0178762B1 (enExample) |
| AT (1) | ATE168006T1 (enExample) |
| AU (1) | AU660153B2 (enExample) |
| CA (1) | CA2093527A1 (enExample) |
| DE (1) | DE69129750T2 (enExample) |
| DK (1) | DK0552205T3 (enExample) |
| ES (1) | ES2118090T3 (enExample) |
| GB (1) | GB9022250D0 (enExample) |
| IE (1) | IE913580A1 (enExample) |
| IL (1) | IL99715A (enExample) |
| TW (1) | TW212756B (enExample) |
| WO (1) | WO1992006688A1 (enExample) |
| ZA (1) | ZA918117B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2180011C (en) * | 1993-12-28 | 2001-05-15 | K. Roger Aoki | Botulinum toxins for treating sweating |
| ES2377126T3 (es) * | 1994-12-12 | 2012-03-22 | Omeros Corporation | Solución de irrigación y utilización de la misma para la inhibición perioperatoria del dolor, la inflamación y/o los espasmos en una estructura vascular |
| US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
| US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
| US20060002989A1 (en) * | 2004-06-10 | 2006-01-05 | Ahmed Salah U | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| SI2124556T1 (sl) | 2006-10-09 | 2015-01-30 | Charleston Laboratories, Inc. | Farmacevtske sestave |
| CA2905541C (en) | 2008-01-09 | 2020-02-11 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
| US8304179B2 (en) * | 2009-05-11 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for manufacturing a semiconductor device using a modified photosensitive layer |
| US20100287502A1 (en) * | 2009-05-11 | 2010-11-11 | Olympus Imaging Corp. | Image search device and image search method |
| EP3311667A1 (en) | 2009-07-08 | 2018-04-25 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| CA3055170A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GR79215B (enExample) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
-
1991
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en not_active Ceased
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 EP EP91917473A patent/EP0552205B1/en not_active Expired - Lifetime
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active Expired - Fee Related
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0552205B1 (en) | 1998-07-08 |
| CA2093527A1 (en) | 1992-04-13 |
| ATE168006T1 (de) | 1998-07-15 |
| AU660153B2 (en) | 1995-06-15 |
| IE913580A1 (en) | 1992-04-22 |
| DE69129750D1 (de) | 1998-08-13 |
| AU8642291A (en) | 1992-05-20 |
| ZA918117B (en) | 1992-08-26 |
| DE69129750T2 (de) | 1998-11-12 |
| KR0178762B1 (ko) | 1999-03-20 |
| IL99715A (en) | 1996-01-19 |
| GB9022250D0 (en) | 1990-11-28 |
| US5376672A (en) | 1994-12-27 |
| DK0552205T3 (da) | 1999-04-19 |
| TW212756B (enExample) | 1993-09-11 |
| JPH06501935A (ja) | 1994-03-03 |
| EP0552205A1 (en) | 1993-07-28 |
| IL99715A0 (en) | 1992-08-18 |
| WO1992006688A1 (en) | 1992-04-30 |
| JP3159263B2 (ja) | 2001-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4340681A1 (es) | Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero | |
| IT1274879B (it) | Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo. | |
| DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| DE69812159D1 (de) | Derivate des adamantan | |
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| NO20002786D0 (no) | Adamantanderivater | |
| IS2034B (is) | Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun | |
| ES2118090T3 (es) | Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene. | |
| SE9402816D0 (sv) | Method and meams for drug administration | |
| PT741716E (pt) | Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem | |
| DK0678026T3 (da) | Anvendelse af carbamazepin og oxcarbazepin ved fremstilling af lægemidler til behandling af Parkinsons sygdom og parkinsonisme-syndromer | |
| CY1118924T1 (el) | Μεθοδος για θεραπεια της πρωτοπαθους αϋπνιας | |
| ZA965969B (en) | Salts derived from amidine and cyclooxygenase inhibitor process for the preparation thereof their application as medicinal drugs and pharmaceutical compositions in which they are contained | |
| DE69226649D1 (de) | Analoge des menschlichen Interleukin-8. | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| SE9402880D0 (sv) | New peptide derivatives | |
| NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
| HUT77175A (hu) | Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények | |
| NZ241234A (en) | Amino polyhydroxy cyclohexane derivatives and medicaments | |
| ATE168681T1 (de) | 3-phenylureido-1,5-benzodiazepin-dione verwendbar als gastrin- oder cck antagonisten | |
| GR3024854T3 (en) | Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances. | |
| ES2036920B1 (es) | Un metodo para la preparacion de un compuesto de dicloroanilina. | |
| ES2175424T3 (es) | Sal de metansulfonato de una arilpiperazina derivada de triptamina y sus solvatos para uso farmaceutico. | |
| SE9404438D0 (sv) | New process | |
| FI960026A0 (fi) | Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 552205 Country of ref document: ES |